Germany launches third DMP (disease management programme) for heart disease:
This article was originally published in Clinica
Executive Summary
Last week the German federal insurance department (BVA) completed its guidelines for the establishment of a disease management programme (DMP) for coronary heart disease. To have a DMP accredited by the (BVA), health insurance funds must devise a programme to reduce morbidity, whilst raising the level of the patient's quality of life. The programme must also carry out diagnosis, such as coronary angiography, and offer interventional therapy, such as coronary revascularisation, in accordance with evidence-based guidelines. This is the third DMP in place since the introduction of programmes for the treatment of diabetes mellitus type II and breast cancer.